Insufficient scRNA-seq data for expression of PGLYRP3 at single-cell level.
Insufficient scRNA-seq data for expression of PGLYRP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 38% | 638.19 | 553 / 1445 | 63% | 41.89 | 115 / 183 |
tonsil | 0% | 0 | 0 / 0 | 87% | 38.18 | 39 / 45 |
skin | 72% | 1428.05 | 1296 / 1809 | 9% | 2.42 | 42 / 472 |
uterus | 1% | 26.96 | 2 / 170 | 46% | 20.65 | 213 / 459 |
lung | 0% | 0 | 0 / 578 | 36% | 10.57 | 421 / 1155 |
bladder | 0% | 0 | 0 / 21 | 22% | 5.65 | 111 / 504 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.60 | 13 / 178 |
intestine | 0% | 0 | 0 / 966 | 6% | 2.13 | 34 / 527 |
stomach | 0% | 0.55 | 1 / 359 | 4% | 0.29 | 12 / 286 |
breast | 0% | 0 | 0 / 459 | 2% | 0.41 | 24 / 1118 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.06 | 6 / 430 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.05 | 5 / 605 |
adipose | 0% | 1.07 | 2 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.53 | 1 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.02 | 1 / 901 |
blood vessel | 0% | 0.82 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0009253 | Biological process | peptidoglycan catabolic process |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0031640 | Biological process | killing of cells of another organism |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0051701 | Biological process | biological process involved in interaction with host |
GO_0016045 | Biological process | detection of bacterium |
GO_0045087 | Biological process | innate immune response |
GO_0032827 | Biological process | negative regulation of natural killer cell differentiation involved in immune response |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0008745 | Molecular function | N-acetylmuramoyl-L-alanine amidase activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016019 | Molecular function | peptidoglycan immune receptor activity |
Gene name | PGLYRP3 |
Protein name | Peptidoglycan recognition protein 3 (Peptidoglycan recognition protein I-alpha) (PGLYRPIalpha) (PGRP-I-alpha) (Peptidoglycan recognition protein intermediate alpha) |
Synonyms | PGRPIA |
Description | FUNCTION: Pattern receptor that binds to murein peptidoglycans (PGN) of Gram-positive bacteria. Has bactericidal activity towards Gram-positive bacteria. May kill Gram-positive bacteria by interfering with peptidoglycan biosynthesis. Binds also to Gram-negative bacteria, and has bacteriostatic activity towards Gram-negative bacteria. Plays a role in innate immunity. . |
Accessions | ENST00000290722.1 Q96LB9 ENST00000683862.1 |